Source: Virtual Congress 2020 – New insights into sleep apnoea: from diagnosis to treatment
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Hao (Shanghai, China), S. Li (Shanghai, China), C. Fu (Shanghai, China). Heterozygous SOD2 deletion deteriorated chronic intermittent hypoxia-induced lung inflammation and vascular remodeling through mtROS-NLRP3 signaling pathway. 2128

Member's Comments

No comment yet.

Related content which might interest you: TSC1/mTOR pathway promotes hypoxia-induced pulmonary hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Sirt3-MnSOD signaling pathway attenuates airway epithelial mitochondrial oxidative stress in chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 TRIM33 prevents pulmonary fibrosis by impairing TGF-ß1 signalling Source: Eur Respir J, 55 (6) 1901346; 10.1183/13993003.01346-2019 Year: 2020 Loss of Bmp9 does not lead to spontaneous pulmonary hypertension, but attenuates vascular remodeling in experimental models Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Overexpression of ISCU can extenuate mitochondrial damage, reduce EMT and bleomycin-induced pulmonary fibrosis Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Targeted gene delivery of BMPR2 attenuates pulmonary hypertension Source: Eur Respir J 2012; 39: 329-343 Year: 2012 Cigarette-decreased NAD/SIRT1 aggravates pulmonary fibrosis by promoting senescence of alveolar type 2 cells through autophagy inhibition and mitochondrial oxidative stress induction Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Functional upregulation of PRMT2 in chronic hypoxia-induced pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004 6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Physical stress modulates distal lung tissue mechanics, inflammation and remodelling associated to iNOS and oxidative stress activation Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015 Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension Source: Eur Respir J, 54 (6) 1900378; 10.1183/13993003.00378-2019 Year: 2019 Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD) Source: ERS Lung Science Conference 2017 Year: 2017 Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 The increased contractility of idiopathic pulmonary fibrosis lung fibroblasts is dependent on angiotensin signalling Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010